My watch list
my.bionity.com  
Login  

Fleming’s method in miniature

02-May-2019

ETH Zürich / Steven Schmitt und Helena Shomar

Micro gel beads with green fluorescent sensor bacteria. In one of the beads (centre), the sensor bacteria were killed by a substance (microscopic view).

Scientists in the Department of Biosystems Science and Engineering at ETH Zurich in Basel have developed a method with which they can quickly test a very large number of molecules for antibiotic effect. With it, they have already successfully discovered new antibiotic candidates produced by microorganisms. In the future, they will use their new technology to examine soil samples and the microbiome on human skin for medically useful microorganisms.

It was 90 years ago that mould accidentally got onto a bacterial culture in Alexander Fleming’s lab. The Scottish bacteriologist observed that the mould produced a substance that killed the bacteria on the cell-culture dish. He had discovered penicillin, one of the first antibiotics. There are now several dozen classes of antibiotics on the market, and scientists continue to search tirelessly for new antimicrobial agents because they are urgently needed in medicine. A large proportion of these drugs are natural products or take these as their origin. And the method of detection is still the same as it was in Fleming’s day: if a substance can kill bacteria on a cell-culture dish, then it’s an antibiotic.

Steven Schmitt and colleagues from ETH Professor Sven Panke’s group in the Department of Biosystems Science and Engineering at ETH Zurich in Basel have now modernised and miniaturised Fleming’s method, making it fit for high-throughput screening of microorganisms and the substances they produce. “While it currently takes up to a year to test around 10,000 producers of substances using conventional methods, we are able to examine millions of variants within just a few days,” says Schmitt, who developed the method as part of his doctoral thesis at ETH.

The ETH scientists, together with Dutch and German colleagues, have successfully identified a number of new antibiotic candidates with the new technology. In a next step, the scientists will investigate whether some of these molecules are suited for medical application.

“Bubble tea” in the quest for active substances

Alexander Fleming used a cell-culture dish with a diameter of ten centimetres, but the new technique, called nanoFleming, employs tiny beads of gel just half a millimetre across – bringing to mind bubble tea or molecular gastronomy’s imitation caviar. Inside these beads, scientists can test new substances for antibiotic activity. For this, they embed numerous sensor bacteria along with one microorganism that produces a substance with a potential antibiotic effect.

If the produced substance has an antibiotic effect, the sensor bacteria die. If it has no effect, they proliferate and form cell clusters. After labelling the sensor bacteria with a fluorescent dye, the scientists can use a high-throughput sorting method to isolate weakly fluorescent gel beads. These contain a microorganism producing an active antibiotic. The scientists can then proceed to identifying this substance.

More effective antibiotics

For their latest paper, which the scientists recently published in the journal Nature Chemical Biology, they tested a collection of 6,000 peptides (short proteins) for antibiotic effect. These molecules are similar to a group of known peptide antibiotics called lantibiotics. The scientists wanted to investigate whether it was possible to increase the efficacy of lantibiotics or bypass known resistance mechanisms by altering their molecular structure in intelligent ways.

Working with fellow Dutch and German scientists, they started from known lantibiotics and their structural and functional subunits. Taking a biotechnology approach, they combined these different subunits in all possible ways and created a collection of microorganisms that produce these recombinant peptides. Testing them with the nanoFleming method the team found 11 peptides that either are effective at smaller doses than the conventional lantibiotics or are able to bypass known resistance mechanisms.

Seeking substances in the natural world

“The method is also excellent for investigating whether microorganisms found in nature produce as yet undiscovered active substances,” says Schmitt. He explained that microbes trying to eliminate their competitors with biochemical compounds is a natural and widespread mechanism. It is therefore possible that new antibiotic classes could be found in habitats such as soil samples or the microbiome found on human skin and in saliva, an area which has not yet been studied in detail. The new technology will be able to analyse microorganisms from these habitats very well. “And because we are now able to test many more producers of active substances in a much shorter time than was possible with previous methods, the chances of discovering active agents from rare microorganisms are far greater.”

The technique could also be adapted to test for additional criteria already during the first screening, such as the stability of antibiotic substances in the human bloodstream or avoidance of resistance mechanisms. Furthermore, it could be possible to equip the gel beads with different kinds of sensor bacteria – those that an active substance absolutely should kill, such as pathogens, and others that it should most definitely not harm, such as beneficial bacteria found on healthy skin or in oral flora.

Schmitt is now pursuing further developments such as these as part of his ETH Pioneer Fellowship. Additional support is provided by a BRIDGE grant, with which the Swiss National Science Foundation and Innosuisse jointly promote developments at the interface between university research and industry. He also plans to establish a spin-off to commercialise the method.

Facts, background information, dossiers
More about ETH Zürich
  • News

    Revolutionising the CRISPR method

    Researchers at ETH Zurich have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously. Everyone’s talking about CRISPR-Cas. This biotechnological method offers a relatively quick and easy way to ... more

    Using algorithms to track down cancer

    Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of t ... more

    Listening to the whispers of individual cells

    For the cells in our bodies to function as a unit, they must communicate with one another constantly. They secrete signalling molecules – ions, proteins and nucleic acids – that are picked up by adjacent cells, which in turn pass on the signal to other cells. Our muscles, digestive system a ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE